Dr. Kate Scrivener, a physiotherapy lecturer and researcher, discusses therapy dosage, stroke mobility outcomes, and teaching neurology. She highlights the importance of education, improving mobility in the community, and increasing therapy doses. Dr. Scrivener's HiWalk trial focuses on improving walking post-stroke through high-dose interventions.